Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
about
Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsAn update on the management of chronic lymphocytic leukaemia.Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.A case of CLL that was successfully treated resulted in the immediate development of AML from a coexistent myeloid line that had been suppressed.Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.Fludarabine in Waldenstrom's macroglobulinemia.Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtypeSimultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms.Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy.Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712Treatment of feline gastrointestinal small-cell lymphoma with chlorambucil and glucocorticoids.Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's MacroglobulinemiaTreatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine?Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.Therapy related acute myeloid leukemia with t(10:16): a rare entityMyelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alphaSecond neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies.Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia.Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.Simultaneous existence of acute myeloid leukemia and chronic lymphocytic leukemia: a case reportIbrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaRole of immunochemotherapy in the treatment of chronic lymphocytic leukemia.Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome.Diffuse large B-cell lymphoma arising independently to lymphoplasmacytic lymphoma: a case of two lymphomas.Concomitant presentation of acute myeloid leukemia with T-cell large granular lymphocytic leukemia.Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaTherapy-related myeloid leukemia.A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.What's all the fuss about? facts and figures about bone marrow failure and conditions.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.A focused review of hematopoietic neoplasms occurring in the therapy-related setting.Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia.Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.
P2860
Q28386366-916C2B12-9C60-47FB-987F-AF3E83DCE6BCQ30341946-CFD5E6D1-F2E2-493E-9A36-D62B8DF7A1DBQ33414468-6D34FD78-EAE6-421B-981C-276277873821Q33421691-23983FC2-BF45-4216-ACEC-AFFEA1CA0187Q33585255-048ACB2F-B127-4A45-8B13-16BA0CD698A2Q33605275-C2AAACCB-91D5-4746-99DA-A8A0BA9B2D66Q34351916-22A8738E-3F48-49F1-A922-10892C6B1055Q34488720-3328C2C8-AFF8-4EBF-9297-7EE86EAD463FQ34519513-DF80385B-99D6-4FDE-80ED-B78D52512EA7Q34870833-85F17BFE-D972-4B24-8B2A-CC60E4C9A9BCQ34879367-0B04576C-0DD3-42F9-ABF4-E6EAA71C53EEQ34971617-0603350D-2980-4D7B-95A4-A7561921C41FQ35136616-481BB7F0-9BE0-4419-ABB9-A7B2F32E5CFAQ35153656-588293BE-4973-4CBF-9060-3AD1FEBCA209Q35192794-19EED341-6242-4C42-B612-1B6DB1F36D4AQ35266160-9E948D32-CCC2-479A-8338-8E5A2ED870D8Q35625192-3200D6A1-567B-4D22-9DF8-06B0493943CBQ35720059-81983D3C-473D-4A2F-9D3B-3B61AB771AECQ35847448-E64B1F18-FDB7-48C7-ACC3-7D98791B61ACQ35994909-B94D6964-3F6F-4595-9BF0-A2BA287CB20AQ36006426-C050C6E5-D869-4447-8A95-9FE00E6E7A5CQ36069481-CC2F96EB-00BF-4701-8E99-7A28F91D5F8FQ36090959-36A2F983-25CE-44C1-AE7B-B11F9491DC7EQ36137351-DD7880DB-C45E-4F0E-873C-9A0B0A561B6FQ36490049-D5FA5859-48AF-467F-B8EF-A24CF4A55510Q36689156-C3FE9A2E-BB97-47A7-9E2E-5C24C1D6217DQ36689790-AFEC5A71-3A9E-4CA9-AFA1-83EBFC6F15DCQ36692782-15F8CCCA-5778-4F41-BA1F-89B1D9EC56FDQ36718506-A71EA47A-5590-4AAF-AC02-F01D82F31195Q36799287-72028A1F-56A3-48A2-99BF-470F018962B3Q36935200-82A785A1-FD32-4416-9B68-088A8A680E4DQ37009760-71D5BF2E-2B5B-4837-AADA-16263E1D055EQ37364653-EBDED5C1-3B32-4E8B-8163-6DF0834E79C8Q37393134-5A69530A-B774-4A7B-A476-466B1BA1EBAEQ38039381-EB276934-2FA7-4A4B-BC7E-7B460C6588ADQ38093037-FF8A9DF3-E23D-4E40-B63E-2CDA8A48880FQ38239675-0E79421F-B23F-44F9-8128-9227A0F9655FQ38248969-2075AA3D-42A7-456E-8B68-22E18189A65EQ38776166-498C2E92-FAFF-4FE3-BB7C-E7067587F14DQ39227230-DAF90CE7-80A5-4721-8DE6-8312232AF6C4
P2860
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@en
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@nl
type
label
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@en
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@nl
prefLabel
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@en
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@nl
P2093
P921
P356
P1476
Therapy-related myeloid leukem ...... cer and leukemia group B 9011.
@en
P2093
Bercedis L Peterson
Charles A Schiffer
John D Hines
Jonathan E Kolitz
Kanti R Rai
Laurence Elias
Lois Shepherd
Vicki A Morrison
P304
P356
10.1200/JCO.2002.08.128
P407
P577
2002-09-01T00:00:00Z